Jasmeet Sidhu

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• Functional precision approach in patients with very high risk acute lymphoblastic leukaemia in India: a single-centre cohort study
  The Lancet Regional Health - Southeast Asia 2026 DOI: 10.1016/j.lansea.2025.100710
  +Save
• Biogeneric Native and Polyethylene Glycol-conjugated Escherichia coli Asparaginases for Treating Children with Acute Lymphoblastic Leukemia.
  Therapeutic drug monitoring 2026 DOI: 10.1097/ftd.0000000000001473
  +Save
• Biogeneric native and polyethylene glycol-conjugated E. coli asparaginases for treating children with acute lymphoblastic leukaemia
  2025 DOI: 10.1101/2025.10.28.25337165
  +Save
• Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic Leukaemia
  Blood 2023 DOI: 10.1182/blood-2023-185989
  +Save
• Phenotypic Drug Response Profiling Identifies Asparaginase-Based Synergistic Combinations for Very High Risk Acute Lymphoblastic Leukaemia
  Blood 2023 DOI: 10.1182/blood-2023-172885
  +Save
• MSC.sensor: Capturing cancer cell interactions with stroma for functional profiling.
  SLAS discovery : advancing life sciences R & D 2023 DOI: 10.1016/j.slasd.2023.08.003
  +Save
• Relapsed Acute Lymphoblastic Leukemia
  Indian Journal of Pediatrics 2023 DOI: 10.1007/s12098-023-04635-4
  +Save
• MSC.sensor: capturing cancer cell interactions with stroma for functional profiling
  2023 DOI: 10.21203/rs.3.rs-2567217/v1
  +Save
• Unique mutation and gene expression in High Hyperdiploid Acute Lymphoblastic Leukaemia with whole chromosome uniparental isodisomy
  2022 DOI: 10.21203/rs.3.rs-1349722/v1
  +Save
• Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia
  Pediatric Hematology Oncology Journal 2022 DOI: 10.1016/j.phoj.2022.10.235
  +Save